BR9812254A - Polymorphic cag gene of contained repetition and its uses - Google Patents

Polymorphic cag gene of contained repetition and its uses

Info

Publication number
BR9812254A
BR9812254A BR9812254-1A BR9812254A BR9812254A BR 9812254 A BR9812254 A BR 9812254A BR 9812254 A BR9812254 A BR 9812254A BR 9812254 A BR9812254 A BR 9812254A
Authority
BR
Brazil
Prior art keywords
repetition
contained
polymorphic
gene
polymorphic cag
Prior art date
Application number
BR9812254-1A
Other languages
Portuguese (pt)
Inventor
Guy A Rouleau
Original Assignee
Univ Mcgill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mcgill filed Critical Univ Mcgill
Publication of BR9812254A publication Critical patent/BR9812254A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"GENE POLIMóRFICO CONTENDO CAG DE REPETIçãO E SEUS USOS". A presente invenção se refere a gene hGT1, um gene polimórfico contendo CAG de repetição e seus usos para o diagnóstico, o prognóstico e o tratamento de doenças psiquiátricas, tais como a esquizofrenia."POLYMORPHIC GENE CONTAINING REPETITION CAG AND ITS USES". The present invention relates to the hGT1 gene, a polymorphic gene containing repeat CAG and its uses for the diagnosis, prognosis and treatment of psychiatric diseases, such as schizophrenia.

BR9812254-1A 1997-09-19 1998-09-18 Polymorphic cag gene of contained repetition and its uses BR9812254A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA 2216057 CA2216057A1 (en) 1997-09-19 1997-09-19 Polymorphic cag repeat-containing gene, diagnosis of psychiatric diseases and therapeutic uses thereof
PCT/CA1998/000884 WO1999015639A1 (en) 1997-09-19 1998-09-18 Polymorphic cag repeat-containing gene and uses thereof

Publications (1)

Publication Number Publication Date
BR9812254A true BR9812254A (en) 2002-07-09

Family

ID=4161505

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9812254-1A BR9812254A (en) 1997-09-19 1998-09-18 Polymorphic cag gene of contained repetition and its uses

Country Status (6)

Country Link
EP (1) EP1015574A1 (en)
JP (1) JP2001517432A (en)
AU (1) AU757556B2 (en)
BR (1) BR9812254A (en)
CA (1) CA2216057A1 (en)
WO (1) WO1999015639A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19835910C1 (en) * 1998-08-07 2000-05-04 Deutsches Krebsforsch Gene isolated on the short arm of human chromosome 17
JP2004522418A (en) * 2000-09-08 2004-07-29 アイオワ ステート ユニバーシティ リサーチ ファウンデーション，インコーポレーティッド Novel PRKAG3 allele and its use as a genetic marker for reproductive and flesh traits
GB0228079D0 (en) * 2002-12-02 2003-01-08 Laxdale Ltd Huntington's Disease
WO2008032056A2 (en) * 2006-09-16 2008-03-20 Genophrenix Limited Dopamine receptor interacting proteins as markers for disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834183A (en) * 1993-06-29 1998-11-10 Regents Of The University Of Minnesota Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis
EP0873132A4 (en) * 1995-11-17 2002-09-18 Univ British Columbia PROTEIN WHICH INTERACTS WITH THE HUNTINGTON'S DISEASE GENE PRODUCT, cDNA CODING THEREFOR, AND ANTIBODIES THERETO

Also Published As

Publication number Publication date
AU757556B2 (en) 2003-02-27
JP2001517432A (en) 2001-10-09
CA2216057A1 (en) 1999-03-19
AU9149598A (en) 1999-04-12
WO1999015639A1 (en) 1999-04-01
EP1015574A1 (en) 2000-07-05

Similar Documents

Publication Publication Date Title
CU23344A3 (en) AZABICICLOALCANS AS MODULATORS OF CCR5
BR0214035A (en) Compound
IL189629A0 (en) Compositions containing human ctla-4 antibodies
AR003962A1 (en) DIHIDRODIBENZO / B, F / AZEPINES USEFUL IN THE TREATMENT OF SOME DISORDERS OF THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM, METHOD FOR PREPARING SUCH COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS, AND THEIR USES
BR9711444A (en) Adenosine derivatives replaced by heterocyclic n6.
AP2000001881A0 (en) 2-(Purine-9-YL)-tetrahydrofuran-3,4 4-diol derivatives.
BR9901491A (en) 7-hetero-bicycles [2.2.1] - heptanes.
BR9801126A (en) 1,4-benzothiazepine-1,1-hypolipidemic dioxides.
TR199901905T2 (en) 2- (P�rin-9-yl) -tetrahidrofuran-3,4-diol t�revleri.
EP1507005A3 (en) Antisense modulation of BCL-X expression
TR200200938T2 (en) Piperidines as CCR5 modulators
BR9916798A (en) 4-arylamino, 4-aryloxy and 4-arylthio diarylamines and their derivatives as selective mek inhibitors
GT199900067A (en) NEW 4-PHENYLPIPERIDINES FOR THE TREATMENT OF PRURTIC DEDERMATOSIS.
TR200100410T2 (en) 2- (purin-9-yl) -tetrahydrofuran-3,4-diol derivatives.
SV1999000102A (en) HETERO-CYCLE COMPOUNDS AS ROTAMASE ENZYME INHIBITORS. REF. PCS 9475 AFAE / BB.
PA8468501A1 (en) HETERO-CYCLIC COMPOUNDS AS ROTHAMASE ENZYME INHIBITORS
DE69229339D1 (en) CRYSTALLINE TIAGABINE HYDROCHLORIDE MONOHYDRATE, ITS PRODUCTION AND USE
BR0213072A (en) Bar soap
DK1123414T3 (en) Antisense modulation of integrin alpha 4. expression
SE9804212D0 (en) Compounds
BR9812254A (en) Polymorphic cag gene of contained repetition and its uses
UY27451A1 (en) 2,5-DIAMIDOINDOLES REPLACED AND ITS USE
SE9802574D0 (en) Novel compounds
ES2169022T3 (en) USE OF DERIVATIVES OF (PIRIDIL-METIL-SULFINIL) -1-H-BENCIMIDAZOL FOR THE TREATMENT OF DISEASES CAUSED BY HELICOBACTER.
DE69913380D1 (en) COMPOSITION FOR THE TREATMENT OF PERIODONTAL DISEASES

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]